[IMJ On-Air] High readmission rates in cirrhotic patients

Pomegranate Health

Hospitalisation rates for cirrhosis are increasing in Australia in part associated with the high prevalence of obesity and subsequent non-alcoholic fatty liver disease. More concerning still is the frequency with which discharged patients are readmitted within 30 days. One systematic review put the average readmission rate at 26%, but the studies cited varied greatly in their inclusion and exclusion criteria and not much is known from Australia and Aotearoa-New Zealand. In the December edition of the Internal Medicine Journal researchers at the Austin Hospital Liver Transplant Unit in Melbourne reported a 46% readmission rate among their patients. This was based on a retrospective audit of medical records, which also suggested that a fifth of readmissions might have been preventable. Better adherence to practice guidelines when patients are first hospitalised for cirrhosis may reduce a significant burden on patients and the healthcare system.

Guests
Professor James O’Beirne FRCP FRACP (Director of Gastroenterology & Hepatology, Sunshine Coast Hospital and Health Service; University of the Sunshine Coast)
Dr Karl Vaz FRACP (Victorian Liver Transplant Unit, Austin Hospital)
Key Reference

• Karl Vaz et al. Rate of early hospital readmission amongst cirrhotic patients is high in Australia: experience from a single liver transplant centre Internal Medicine Journl 2021; 52(12)
• Free access to IMJ for members of the RACP

Please visit the Pomegranate Health web page for a transcript and supporting references. To claim learning credits login to MyCPD. Subscribe to new episode email alerts or search for ‘Pomegranate Health’ in Apple Podcasts, Spotify, Castbox, or any podcasting app.